EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
Article
Guo, Deliang, Prins, Robert M, Dang, Julie et al. (2009). EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
. 2(101), 10.1126/scisignal.2000446
Guo, Deliang, Prins, Robert M, Dang, Julie et al. (2009). EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
. 2(101), 10.1126/scisignal.2000446
Guo, Deliang; Prins, Robert M; Dang, Julie; Kuga, Daisuke; Iwanami, Akio; Soto, Horacio; Lin, Kelly Y; Huang, Tiffany T; Akhavan, David; Hock, M Benjamin; Zhu, Shaojun; Kofman, Ava A; Bensinger, Steve J; Yong, William H; Vinters, Harry V; Horvath, Steve; Watson, Andrew D; Kuhn, John G; Robins, H Ian; Mehta, Minesh P; Wen, Patrick Y; DeAngelis, Lisa M; Prados, Michael D; Mellinghoff, Ingo K; Cloughesy, Timothy F; Mischel, Paul S
